Skip to main content
Top
Published in: International Urology and Nephrology 3/2024

24-08-2023 | Furosemide | Nephrology - Original Paper

Early repeat hospitalization for fluid overload in individuals with cardiovascular disease and risks: a retrospective cohort study

Authors: Cynthia C. Lim, Dorothy Huang, Zhihua Huang, Li Choo Ng, Ngiap Chuan Tan, Wei Yi Tay, Yong Mong Bee, Andrew Ang, Chieh Suai Tan

Published in: International Urology and Nephrology | Issue 3/2024

Login to get access

Abstract

Aims

Fluid overload is a common manifestation of cardiovascular and kidney disease and a leading cause of hospitalizations. To identify patients at risk of recurrent severe fluid overload, we evaluated the incidence and risk factors associated with early repeat hospitalization for fluid overload among individuals with cardiovascular disease and risks.

Methods

Single-center retrospective cohort study of 3423 consecutive adults with an index hospitalization for fluid overload between January 2015 and December 2017 and had cardiovascular risks (older age, diabetes mellitus, hypertension, dyslipidemia, kidney disease, known cardiovascular disease), but excluded if lost to follow-up or eGFR < 15 ml/min/1.73 m2. The outcome was early repeat hospitalization for fluid overload within 30 days of discharge.

Results

The mean age was 73.9 ± 11.6 years and eGFR was 54.1 ± 24.6 ml/min/1.73 m2 at index hospitalization. Early repeat hospitalization for fluid overload occurred in 291 patients (8.5%). After adjusting for demographics, comorbidities, clinical parameters during index hospitalization and medications at discharge, cardiovascular disease (adjusted odds ratio, OR 1.66, 95% CI 1.27–2.17), prior hospitalization for fluid overload within 3 months (OR 2.52, 95% CI 1.17–5.44), prior hospitalization for any cause in within 6 months (OR 1.33, 95% CI 1.02–1.73) and intravenous furosemide use (OR 1.58, 95% CI 1.10–2.28) were associated with early repeat hospitalization for fluid overload. Higher systolic BP on admission (OR 0.992, 95% 0.986–0.998) and diuretic at discharge (OR 0.50, 95% CI 0.26–0.98) reduced early hospitalization for fluid overload.

Conclusion

Patients at-risk of early repeat hospitalization for fluid overload may be identified using these risk factors for targeted interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mayne KJ, Shemilt R, Keane DF, Lees JS, Mark PB, Herrington WG (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. J Card Fail 28(11):1628–1641CrossRefPubMed Mayne KJ, Shemilt R, Keane DF, Lees JS, Mark PB, Herrington WG (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. J Card Fail 28(11):1628–1641CrossRefPubMed
2.
go back to reference Zoccali C, Mallamaci F (2018) Mapping progress in reducing cardiovascular risk with kidney disease: managing volume overload. Clin J Am Soc Nephrol 13(9):1432CrossRefPubMedPubMedCentral Zoccali C, Mallamaci F (2018) Mapping progress in reducing cardiovascular risk with kidney disease: managing volume overload. Clin J Am Soc Nephrol 13(9):1432CrossRefPubMedPubMedCentral
3.
go back to reference Koratala A, Ronco C, Kazory A (2022) Diagnosis of fluid overload: from conventional to contemporary concepts. Cardiorenal Med 12(4):141–154CrossRefPubMed Koratala A, Ronco C, Kazory A (2022) Diagnosis of fluid overload: from conventional to contemporary concepts. Cardiorenal Med 12(4):141–154CrossRefPubMed
4.
go back to reference Blecker S, Ladapo JA, Doran KM, Goldfeld KS, Katz S (2014) Emergency department visits for heart failure and subsequent hospitalization or observation unit admission. Am Heart J 168(6):901-908.e901CrossRefPubMedPubMedCentral Blecker S, Ladapo JA, Doran KM, Goldfeld KS, Katz S (2014) Emergency department visits for heart failure and subsequent hospitalization or observation unit admission. Am Heart J 168(6):901-908.e901CrossRefPubMedPubMedCentral
5.
go back to reference Ronksley PE, Tonelli M, Manns BJ et al (2017) Emergency department use among patients with CKD: a population-based analysis. Clin J Am Soc Nephrol 12(2):304CrossRefPubMedPubMedCentral Ronksley PE, Tonelli M, Manns BJ et al (2017) Emergency department use among patients with CKD: a population-based analysis. Clin J Am Soc Nephrol 12(2):304CrossRefPubMedPubMedCentral
6.
go back to reference Ambrosy AP, Fonarow GC, Butler J et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63(12):1123–1133CrossRefPubMed Ambrosy AP, Fonarow GC, Butler J et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63(12):1123–1133CrossRefPubMed
7.
go back to reference Costanzo MR, Fonarow GC, Rizzo JA (2019) Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis. J Med Econ 22(6):577–583CrossRefPubMed Costanzo MR, Fonarow GC, Rizzo JA (2019) Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis. J Med Econ 22(6):577–583CrossRefPubMed
8.
go back to reference Mark PB, Mangion K, Rankin AJ et al (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clin Kidney J 15(12):2186–2199CrossRefPubMedPubMedCentral Mark PB, Mangion K, Rankin AJ et al (2022) Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients. Clin Kidney J 15(12):2186–2199CrossRefPubMedPubMedCentral
9.
go back to reference McHugh K, DeVore AD, Wu J et al (2019) Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol 73(5):602–611CrossRefPubMed McHugh K, DeVore AD, Wu J et al (2019) Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol 73(5):602–611CrossRefPubMed
10.
go back to reference Kasiakogias A, Rosei EA, Camafort M et al (2021) Hypertension and heart failure with preserved ejection fraction: position paper by the European society of hypertension. J Hypertens 39(8):1522–1545CrossRefPubMed Kasiakogias A, Rosei EA, Camafort M et al (2021) Hypertension and heart failure with preserved ejection fraction: position paper by the European society of hypertension. J Hypertens 39(8):1522–1545CrossRefPubMed
11.
go back to reference Van Grootven B, Jepma P, Rijpkema C et al (2021) Prediction models for hospital readmissions in patients with heart disease: a systematic review and meta-analysis. BMJ Open 11(8):e047576CrossRefPubMedPubMedCentral Van Grootven B, Jepma P, Rijpkema C et al (2021) Prediction models for hospital readmissions in patients with heart disease: a systematic review and meta-analysis. BMJ Open 11(8):e047576CrossRefPubMedPubMedCentral
13.
go back to reference Bahar J, Rahman A, Wong G et al (2022) 126 Safety and effectiveness of acute heart failure care as outpatient (safe): a meta-analysis of studies comparing outpatient based management with standard inpatient care. BMJ Publishing Group Ltd and British Cardiovascular Society Bahar J, Rahman A, Wong G et al (2022) 126 Safety and effectiveness of acute heart failure care as outpatient (safe): a meta-analysis of studies comparing outpatient based management with standard inpatient care. BMJ Publishing Group Ltd and British Cardiovascular Society
14.
15.
16.
go back to reference Mahmoudi E, Kamdar N, Kim N, Gonzales G, Singh K, Waljee AK (2020) Use of electronic medical records in development and validation of risk prediction models of hospital readmission: systematic review. BMJ 2020(369):m958CrossRef Mahmoudi E, Kamdar N, Kim N, Gonzales G, Singh K, Waljee AK (2020) Use of electronic medical records in development and validation of risk prediction models of hospital readmission: systematic review. BMJ 2020(369):m958CrossRef
17.
go back to reference Low LL, Liu N, Wang S, Thumboo J, Ong MEH, Lee KH (2016) Predicting 30-day readmissions in an Asian population: building a predictive model by incorporating markers of hospitalization severity. PLoS One 11(12):e0167413CrossRefPubMedPubMedCentral Low LL, Liu N, Wang S, Thumboo J, Ong MEH, Lee KH (2016) Predicting 30-day readmissions in an Asian population: building a predictive model by incorporating markers of hospitalization severity. PLoS One 11(12):e0167413CrossRefPubMedPubMedCentral
18.
go back to reference van Walraven C, Dhalla IA, Bell C et al (2010) Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. Can Med Assoc J 182(6):551CrossRef van Walraven C, Dhalla IA, Bell C et al (2010) Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. Can Med Assoc J 182(6):551CrossRef
19.
go back to reference Zhou H, Della PR, Roberts P, Goh L, Dhaliwal SS (2016) Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open 6(6):e011060CrossRefPubMedPubMedCentral Zhou H, Della PR, Roberts P, Goh L, Dhaliwal SS (2016) Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open 6(6):e011060CrossRefPubMedPubMedCentral
21.
go back to reference Arora S, Patel P, Lahewala S et al (2017) Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol 119(5):760–769CrossRefPubMed Arora S, Patel P, Lahewala S et al (2017) Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol 119(5):760–769CrossRefPubMed
22.
go back to reference Masella C, Viggiano D, Molfino I et al (2019) Diuretic resistance in cardio-nephrology: role of pharmacokinetics, hypochloremia, and kidney remodeling. Kidney Blood Press Res 44(5):915–927CrossRefPubMed Masella C, Viggiano D, Molfino I et al (2019) Diuretic resistance in cardio-nephrology: role of pharmacokinetics, hypochloremia, and kidney remodeling. Kidney Blood Press Res 44(5):915–927CrossRefPubMed
23.
go back to reference Rahman F, McEvoy JW (2017) The J-shaped curve for blood pressure and cardiovascular disease risk: historical context and recent updates. Curr Atheroscler Rep 19(8):34CrossRefPubMed Rahman F, McEvoy JW (2017) The J-shaped curve for blood pressure and cardiovascular disease risk: historical context and recent updates. Curr Atheroscler Rep 19(8):34CrossRefPubMed
24.
go back to reference Jiang C, Wu S, Wang M, Zhao X, Li H (2021) J-curve relationship between admission SBP and 2-year cardiovascular mortality in older patients admitted for acute coronary syndrome. J Hypertens 39(5):926CrossRefPubMed Jiang C, Wu S, Wang M, Zhao X, Li H (2021) J-curve relationship between admission SBP and 2-year cardiovascular mortality in older patients admitted for acute coronary syndrome. J Hypertens 39(5):926CrossRefPubMed
25.
go back to reference Low LL, Vasanwala FF, Ng LB, Chen C, Lee KH, Tan SY (2015) Effectiveness of a transitional home care program in reducing acute hospital utilization: a quasi-experimental study. BMC Health Serv Res 15(1):1–8CrossRef Low LL, Vasanwala FF, Ng LB, Chen C, Lee KH, Tan SY (2015) Effectiveness of a transitional home care program in reducing acute hospital utilization: a quasi-experimental study. BMC Health Serv Res 15(1):1–8CrossRef
26.
go back to reference Bamforth RJ, Chhibba R, Ferguson TW et al (2021) Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: a systematic review and meta-analysis. PLoS One 16(4):e0249542CrossRefPubMedPubMedCentral Bamforth RJ, Chhibba R, Ferguson TW et al (2021) Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: a systematic review and meta-analysis. PLoS One 16(4):e0249542CrossRefPubMedPubMedCentral
27.
go back to reference Ibrahim AM, Koester C, Al-Akchar M et al (2020) HOSPITAL Score, LACE Index and LACE+ Index as predictors of 30-day readmission in patients with heart failure. BMJ Evid Based Med 25(5):166–167CrossRefPubMed Ibrahim AM, Koester C, Al-Akchar M et al (2020) HOSPITAL Score, LACE Index and LACE+ Index as predictors of 30-day readmission in patients with heart failure. BMJ Evid Based Med 25(5):166–167CrossRefPubMed
28.
go back to reference Yazdan-Ashoori P, Lee SF, Ibrahim Q, Van Spall HGC (2016) Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure. Am Heart J 179:51–58CrossRefPubMed Yazdan-Ashoori P, Lee SF, Ibrahim Q, Van Spall HGC (2016) Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure. Am Heart J 179:51–58CrossRefPubMed
29.
go back to reference Auerbach AD, Kripalani S, Vasilevskis EE et al (2016) Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med 176(4):484–493CrossRefPubMedPubMedCentral Auerbach AD, Kripalani S, Vasilevskis EE et al (2016) Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med 176(4):484–493CrossRefPubMedPubMedCentral
30.
go back to reference Meurs EA, Siegert CE, Uitvlugt E et al (2021) Clinical characteristics and risk factors of preventable hospital readmissions within 30 days. Sci Rep 11(1):1–8CrossRef Meurs EA, Siegert CE, Uitvlugt E et al (2021) Clinical characteristics and risk factors of preventable hospital readmissions within 30 days. Sci Rep 11(1):1–8CrossRef
31.
go back to reference McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA (2014) Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One 9(8):e104519ADSCrossRefPubMedPubMedCentral McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA (2014) Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One 9(8):e104519ADSCrossRefPubMedPubMedCentral
32.
go back to reference Worster A, Balion CM, Hill SA et al (2008) Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review. Clin Biochem 41(4):250–259CrossRefPubMed Worster A, Balion CM, Hill SA et al (2008) Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review. Clin Biochem 41(4):250–259CrossRefPubMed
33.
go back to reference van der Aart-van der Beek AB, de Boer RA, Heerspink HJ (2022) Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 18(5):294–306CrossRefPubMed van der Aart-van der Beek AB, de Boer RA, Heerspink HJ (2022) Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 18(5):294–306CrossRefPubMed
34.
go back to reference Carlson MD, Roy B, Groenewoud AS (2020) Assessing quantitative comparisons of health and social care between countries. JAMA 324(5):449–450CrossRefPubMed Carlson MD, Roy B, Groenewoud AS (2020) Assessing quantitative comparisons of health and social care between countries. JAMA 324(5):449–450CrossRefPubMed
Metadata
Title
Early repeat hospitalization for fluid overload in individuals with cardiovascular disease and risks: a retrospective cohort study
Authors
Cynthia C. Lim
Dorothy Huang
Zhihua Huang
Li Choo Ng
Ngiap Chuan Tan
Wei Yi Tay
Yong Mong Bee
Andrew Ang
Chieh Suai Tan
Publication date
24-08-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03747-2

Other articles of this Issue 3/2024

International Urology and Nephrology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine